Bg pattern

ACUOLENS 3 mg/ml + 5.5 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use ACUOLENS 3 mg/ml + 5.5 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Leaflet:information for the user

ACUOLENS 3 mg/ml + 5.5 mg/ml eye drops in single-dose solution

Hypromellose / Sodium chloride

Read the entire leaflet carefully before starting to usethis medication, as it contains important information for you.

Follow the administration instructions for the medication contained in this leaflet or as indicated by your doctor or pharmacist.

  • Keep this leaflet, as you may need to read it again.
  • If you need advice or more information, consult your pharmacist.
  • If you experience side effects, consult your doctor or pharmacist, even if they are side effects not listed in this leaflet. See section 4.
  • You should consult a doctor if it worsens or does not improve after 3 days.

Contents of the leaflet

  1. What is ACUOLENS and what is it used for
  2. What you need to know before starting to use ACUOLENS
  3. How to use ACUOLENS
  4. Possible side effects
  5. Storage of ACUOLENS
  6. Contents of the package and additional information

1. What is ACUOLENS and what is it used for

ACUOLENS is an eye drop that, due to its components, hypromellose and sodium chloride, lubricates and protects the cornea, relieving any discomfort (dryness and irritation) caused by decreased tear production.

It is used for the symptomatic relief of irritation and dryness of the eyes.

You should consult a doctor if it worsens or does not improve after 3 days.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before starting to use ACUOLENS

Do not use ACUOLENS

  • if you are allergic to hypromellose, sodium chloride, or any of the other components of this medication (listed in section 6).

Warnings and precautions

Consult your doctor or pharmacist before starting to use ACUOLENS.

Use this medication only in your eye(s).

If you experience headache, eye pain, changes in vision, eye irritation, continued redness, or if symptoms worsen or persist for more than 3 days, discontinue treatment and consult your doctor.

Children

No specific studies have been conducted in children. Consult your doctor before using this medication in children.

Other medications and ACUOLENS

Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medication.

Pregnancy, breastfeeding, and fertility

Consult your doctor before using any medication.

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

This medication can be used during pregnancy and breastfeeding.

Driving and using machines

Like other eye drops, immediately after applying this medication, you may notice that your vision becomes blurry. Do not drive or use machines until your vision is clear.

ACUOLENS contains phosphate buffer

This medication contains 2 mg of phosphates in each 0.5 ml.

If you have severe corneal damage (the transparent layer on the front of the eye), treatment with phosphates, in very rare cases, can cause blurry vision due to calcium accumulation.

3. How to use ACUOLENS

Follow the administration instructions for the medication contained in this leaflet or as indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.

The recommended dose is:

Adults (including elderly patients)

Instill 1 or 2 drops into each affected eye, as needed.

The number of daily applications and the duration of treatment may be modified according to medical criteria.

Recommendations for use:

Hand holding a cartridge with a visible needle preparing for injection with fingers positioned on the sidesHands holding an insulin applicator with a visible needle preparing for injectionDrops of medication being applied directly to the open eye with the lower eyelid pulled down

1 2 3

  1. Open the aluminum pouch and take the single-dose strip.
  2. Hold the strip with the smooth long end facing up and separate one of the single doses by pulling it towards you while keeping the others firmly held. You will need to detach the points where it is attached to the other single doses (figure 1).
  3. Keep the separated single dose. Put the rest of the single doses back in the aluminum pouch.
  4. Make sure you have a mirror and wash your hands.
  5. Hold the smooth long end of the single dose between your fingers and open it by twisting the other end (figure 2).
  6. Tilt your head back. Gently separate the lower eyelid from the eye with a finger, until a pocket forms, where the drop should fall (figure 3).
  7. Hold the single dose between your fingers with the open tip facing down.
  8. Bring the tip of the container close to the eye. A mirror may be helpful.
  9. Do not touch the eye, eyelid, or surrounding areas with the tip of the container. The drops may become contaminated.
  10. Gently squeeze the container to release one drop into the pocket formed between the eyelid and the eye.
  11. If you are applying drops to both eyes, repeat the previous steps for the other eye, using the same container.
  12. Discard the container and any remaining solution immediately.
  13. Discard any unused container one week after opening the aluminum pouch, even if the containers are still unopened.

If a drop falls outside the eye, try again.

If you are using other eye medications, wait at least 5 minutes between the administration of this eye drop and other eye medications. Eye ointments should be administered last.

If you use more ACUOLENS than you should, you can eliminate it by rinsing your eyes with warm water.

Due to the characteristics of this preparation, intoxication phenomena are not expected with the ocular use of the product.

In case of overdose or accidental ingestion, consult your doctor or call the Toxicology Information Service immediately, phone 91 562 04 20, indicating the medication and the amount used.

If you forget to use ACUOLENS, do not worry, apply the drops as soon as possible. Do not apply a double dose to make up for forgotten doses.

If you have any other questions about using this medication, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medications, this medication can cause side effects, although not everyone experiences them.

Observed side effects.

Frequency not known(frequency cannot be estimated from available data):

  • Eye effects: blurred vision, eye pain, abnormal sensation in the eye, eye irritation, eye redness, eye allergy, and eye itching
  • Body effects: allergic reaction (hypersensitivity)

Reporting side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medications: https://www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.

5. Storage of ACUOLENS

Keep this medication out of sight and reach of children.

No special storage conditions are required.

Do not use this medication after the expiration date shown on the single dose and on the box after "EXP". The expiration date is the last day of the month indicated.

You must discard the single dose as soon as you have used it.Once the aluminum pouch is opened, discard any unused single doses one week after opening.

Medications should not be thrown down the drain or into the trash. Deposit the containers and medications you no longer need at the SIGRE collection point in the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medications you no longer need. This will help protect the environment.

6. Contents of the package and additional information

Composition of ACUOLENS

  • The active ingredients are hypromellose and sodium chloride. One ml of solution contains 3 mg of hypromellose and 5.5 mg of sodium chloride.
  • The other components are potassium chloride, magnesium chloride hexahydrate, calcium chloride dihydrate, zinc chloride, disodium hydrogen phosphate dodecahydrate, sodium phosphate monobasic monohydrate, sodium hydrogen carbonate, and purified water.

Appearance of the product and contents of the package

This medication is a liquid (clear and colorless) that comes in a box of 30 single-dose plastic containers of 0.5 ml.

Marketing authorization holder and manufacturer

Marketing authorization holder

Alcon Healthcare S.A.

World Trade Center Almeda Park

Plaça de la Pau s/n, Edificio 6, planta 3

08940 - Cornellà de Llobregat (Barcelona)

Spain

Manufacturer

Alcon-Couvreur N.V.

Rijksweg 14

B-2870 Puurs

Belgium

or

Alcon Laboratories Belgium

Lichterveld 3

2870 Puurs-Sint-Amands

Belgium

Date of the last revision of this leaflet: August 2022

Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for ACUOLENS 3 mg/ml + 5.5 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS

Discuss questions about ACUOLENS 3 mg/ml + 5.5 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for ACUOLENS 3 mg/ml + 5.5 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS?
ACUOLENS 3 mg/ml + 5.5 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in ACUOLENS 3 mg/ml + 5.5 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS?
The active ingredient in ACUOLENS 3 mg/ml + 5.5 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS is artificial tears and other indifferent preparations. This information helps identify medicines with the same composition but different brand names.
How much does ACUOLENS 3 mg/ml + 5.5 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS cost in pharmacies?
The average pharmacy price for ACUOLENS 3 mg/ml + 5.5 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS is around 8.6 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures ACUOLENS 3 mg/ml + 5.5 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS?
ACUOLENS 3 mg/ml + 5.5 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS is manufactured by Alcon Healthcare S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of ACUOLENS 3 mg/ml + 5.5 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether ACUOLENS 3 mg/ml + 5.5 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to ACUOLENS 3 mg/ml + 5.5 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS?
Other medicines with the same active substance (artificial tears and other indifferent preparations) include ARTIFIC 3.20 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS, ARTIFIC 3.20 mg/ml EYE DROPS SOLUTION, CARMELOSE QUALIGEN 5 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media